Venexia Walker
Venexia Walker
University of Bristol, University of Pennsylvania
Verified email at - Homepage
Cited by
Cited by
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
J Zheng, V Haberland, D Baird, V Walker, PC Haycock, MR Hurle, ...
Nature Genetics 52 (10), 1122-1131, 2020
Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities
VM Walker, G Davey Smith, NM Davies, RM Martin
International journal of epidemiology 46 (6), 2078-2089, 2017
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales
R Knight, V Walker, S Ip, JA Cooper, T Bolton, S Keene, R Denholm, ...
Circulation 146 (12), 892-906, 2022
Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource
A Wood, R Denholm, S Hollings, J Cooper, S Ip, V Walker, S Denaxas, ...
bmj 373, 2021
Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation
MJ Ponsford, A Gkatzionis, VM Walker, AJ Grant, RE Wootton, LSP Moore, ...
Circulation 142 (18), 1791-1793, 2020
Mendelian randomization for studying the effects of perturbing drug targets
D Gill, MK Georgakis, VM Walker, AF Schmidt, A Gkatzionis, DF Freitag, ...
Wellcome Open Research 6, 2021
Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes
VM Walker, NM Davies, G Hemani, J Zheng, PC Haycock, TR Gaunt, ...
Wellcome Open Research 4, 2019
Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
VM Walker, PG Kehoe, RM Martin, NM Davies
International journal of epidemiology 49 (4), 1132-1140, 2020
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England
WN Whiteley, S Ip, JA Cooper, T Bolton, S Keene, V Walker, R Denholm, ...
PLoS medicine 19 (2), e1003926, 2022
Prioritizing the role of major lipoproteins and subfractions as risk factors for peripheral artery disease
MG Levin, V Zuber, VM Walker, D Klarin, J Lynch, R Malik, AW Aday, ...
Circulation 144 (5), 353-364, 2021
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
EMF Horne, WJ Hulme, RH Keogh, TM Palmer, EJ Williamson, ...
bmj 378, 2022
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study
J Zheng, M Xu, V Walker, J Yuan, R Korologou-Linden, J Robinson, ...
Diabetologia 65 (10), 1664-1675, 2022
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
J Yarmolinsky, V Díez-Obrero, TG Richardson, M Pigeyre, J Sjaarda, ...
PLoS medicine 19 (2), e1003897, 2022
Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease
J Zheng, Y Zhang, H Rasheed, V Walker, Y Sugawara, J Li, Y Leng, ...
International journal of epidemiology 50 (6), 1995-2010, 2021
Association Between Genetic Variation in Blood Pressure and Increased Lifetime Risk of Peripheral Artery Disease
MG Levin, D Klarin, VM Walker, D Gill, J Lynch, JN Hellwege, JM Keaton, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 41 (6), 2027-2034, 2021
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP
WJ Hulme, EMF Horne, EPK Parker, RH Keogh, EJ Williamson, V Walker, ...
bmj 380, 2023
Comparison of antihypertensive drug classes for dementia prevention
VM Walker, NM Davies, RM Martin, PG Kehoe
Epidemiology (Cambridge, Mass.) 31 (6), 852, 2020
Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: a multivariable Mendelian randomization study
JA Bell, TG Richardson, Q Wang, E Sanderson, T Palmer, V Walker, ...
The Lancet Regional Health–Europe 21, 2022
Comparison with randomized controlled trials as a strategy for evaluating instruments in Mendelian randomization
D Gill, VM Walker, RM Martin, NM Davies, I Tzoulaki
International journal of epidemiology 49 (4), 1404-1406, 2020
Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression
RE Mitchell, AE Hartley, VM Walker, A Gkatzionis, J Yarmolinsky, JA Bell, ...
PLoS genetics 19 (2), e1010596, 2023
The system can't perform the operation now. Try again later.
Articles 1–20